ALX Oncology Holdings Inc.

ALXO

Healthcare Biotechnology

EPS
+73.5%
Free cash flow
+31.7%
Total debt
−3.34%

Quarter to June 2026, against a year earlier

1.16 0.01 +0.87%
Market cap
$159.7M
P/E
n/m
Fwd P/E
n/m
Dividend yield
—
F-score
n/a
ROIC
−673.3%
Net debt / EBITDA
0.3×
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Total current assets
143.46 145.56 50.73 66.52
Total non-current assets
17.36 32.76 8.32 16.21
Total Assets
160.82 178.33 59.05 82.72
Total current liabilities
14.78 20.18 24.55 27.72
Total non-current liabilities
9.86 6.80 8.51 10.20
Total liabilities
24.63 26.98 33.07 37.92
Common Equity (Total)
136.19 151.35 25.98 44.80
Shareholders Equity (Total)
136.19 151.35 25.98 44.80
Total Debt
9.71 8.51 9.75 10.11

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 26 Oct 2026